Globe Newswire » trang 208 » Trang Công Nghệ | Trangcongnghe.vn

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]

Globenewswire -

Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich

Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich

Globenewswire -

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

Globenewswire -

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T

Globenewswire -

Copenhagen Infrastructure Partners and PensionDanmark launch microgrid specialist company

Copenhagen Infrastructure Partners and PensionDanmark launch microgrid specialist company

Globenewswire -

Ascom launches share buyback program

Ascom launches share buyback program

Globenewswire -

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

Globenewswire -

XEM THÊM TIN MỚI